Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SOAT1 | P35610 | 6/20 | 0.44 |
| ▸ | CASR | P41180 | 3/20 | 0.37 |
| ▸ | BCHE | P06276 | 1/20 | 0.34 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.34 |
| ▸ | HTR2A | P28223 | 1/20 | 0.33 |
| ▸ | HTR2C | P28335 | 1/20 | 0.33 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6282714 | 0.86 | SOAT1 (0.37) | SOAT1CASR | |
| Hydrochloric Acid SCHEMBL6285697 | 0.82 | SOAT1 (0.65) | SOAT1 | |
| SCHEMBL4513891 | 0.75 | SOAT1 (0.65) | SOAT1 | |
| SCHEMBL6280606 | 0.73 | — | — | |
| SCHEMBL8856109 | 0.73 | HDAC6 (0.39) | SOAT1 | |
| SCHEMBL8325945 | 0.72 | SOAT1 (0.47) | SOAT1 | |
| SCHEMBL8326103 | 0.72 | SOAT1 (0.47) | SOAT1 | |
| Hydrochloric Acid SCHEMBL6283766 | 0.72 | SOAT1 (0.59) | SOAT1 | |
| Hydrochloric Acid SCHEMBL6285210 | 0.71 | SOAT1 (0.58) | SOAT1 | |
| Hydrochloric Acid SCHEMBL6285720 | 0.71 | SOAT1 (0.58) | SOAT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6969711-B2 | Cyclic diamine compounds and medicine containing the same | KOWA COMPANY, LTD. (JP) | 2005-11-29 | — | — | US | disclosed |
| US-20040038987-A1 | Novel cyclic diamine compounds and medicine containing the same | KOWA COMPANY, LTD. (JP) | 2004-02-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040038987-A1 | Novel cyclic diamine compounds and medicine containing the same | LCAT, ACAT2, ACAT1 | SOAT1 5/4885CASR 4250/4885BCHE 1826/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.